SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001829126-22-014208
Filing Date
2022-07-08
Accepted
2022-07-08 18:00:19
Documents
1
Period of Report
2022-07-06

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 5172
  Complete submission text file 0001829126-22-014208.txt   7122
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Issuer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR. NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR. NEW YORK NY 10036 646 768 8417
Activist Investing LLC (Reporting) CIK: 0001817604 (see all company filings)

State of Incorp.: NY | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-13341 | Film No.: 221075468

Mailing Address VILLA 1, 14-43RD STREET JUMEIRAH 2 DUBAI C0 00000
Business Address
Lazar David E. (Reporting) CIK: 0001932843 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-13341 | Film No.: 221075469